Purdue Pharma

The prescribing culture shifted dramatically that decade thanks in part to a massive marketing campaign by pharmaceutical companies including Stamford-based Purdue Pharma, makers of OxyContin, which was released in 1996. The pro-opioid marketing initially included faulty claims that the risk of ...

Last Friday a King County judge ruled to reject OxyContin manufacturer Purdue Pharma's request to dismiss the lawsuit for provoking the opioid epidemic in Washington state. The lawsuit was filed by Washington State Attorney General Bob Ferguson. Ferguson's lawsuit seeks forfeiture of Washington's ...

Though Purdue Pharma recently stopped marketing Oxycontin to doctors, it's still at the center of the nationwide furor and lawsuits over drugmakers' role in the opioid crisis. With commercial operation reduced, perhaps it's time to focus more on R&D, and Purdue has a new leader for it. John Renger, Ph.D., ...

Opioids Drug Market Global Top Manufacturers 2018: Purdue Pharma, J&J, Teva, Mylan, Depomed. April 13, 2018 - by Prashant · Opioids Drug Market. Global Opioids Drug Market Growth Rate 2018- 2023. Opioids Drug Market. MarketNReports from its Database gives research study on “Opioids Drug market” reports.

Purdue Pharma's alleged role in fueling the nationwide opioid crisis could be headed to trial. A Cleveland-based federal judge overseeing hundreds of complaints from local and state governments against the Stamford-based company and other opioid makers this week said settlement discussions had ...

The Navajo lawsuit names as defendants manufacturers Purdue Pharma and Endo Health Solutions and distributors McKesson Corp., Cardinal Health and AmerisourceBergen. Other defendants include pharmacies: CVS Health, Walgreens Boots Alliance and Walmart. “For generations, Native Americans ...

In recent months, as protesters have begun pressuring the Metropolitan Museum of Art in New York and other cultural institutions to spurn donations from the Sacklers, one branch of the family has moved aggressively to distance itself from OxyContin and its manufacturer, Purdue Pharma. The widow and ...

Under siege for promoting opioids, Purdue Pharma now backs efforts to fight the epidemic. By Jenny Gold. | Kaiser Health ... The money behind these efforts to combat the opioid epidemic and its side effects comes from a perhaps unlikely sponsor: Purdue Pharma, the Stamford, Conn.-based company that ...

Big pharma heir David Sackler has snapped up a funky 1980s architectural home in the posh Bel Air neighborhood of Los Angeles. Mr. Sackler—whose father, Richard S. Sackler, headed Purdue Pharma and famously developed pain opioid Oxycontin—bought the 10,000-square-foot mansion centered ...

The U.S. Department of Justice announced this week it would seek reimbursement from Purdue Pharma and other makers of prescription narcotics for federal health and law-enforcement costs incurred from the opioid crisis. Repayment would come from a prospective settlement or judgment in a ...

The opioid epidemic just got more painful for Purdue Pharma LP and other makers of the pain-killing drugs as the U.S. government said it'll seek reimbursement from the companies for tax dollars spent battling the public-health crisis. The U.S. Justice Department said it'll argue that it's entitled to a portion of ...

STAMFORD — OxyContin maker Purdue Pharma ranked as the top donor among a group of five pharmaceutical companies that poured millions of dollars during the past five years into prominent nonprofits supporting large-scale opioid use, according to a new report from U.S. Sen. Claire McCaskill.

When I got out of treatment I decided to make the personal political by telling my story and turning it into activism. My fight is against those who are responsible for the opioid crisis. I am specifically targeting the Sackler family, the private owners of Purdue Pharma who manufacture and distribute the drug ...

Embattled Purdue Pharma laid off about 100 employees this week as the company continues to restructure, Hearst Connecticut Media has learned. In the past few weeks, the maker of the controversial OxyContin painkiller has undergone some of its most extensive organizational changes to date.

Purdue Pharma introduced Oxycontin in 1995. It was Purdue Pharma's breakthrough palliative for chronic pain. Under a marketing strategy that Arthur Sackler had pioneered decades earlier, the company aggressively pressed doctors to prescribe the drug. The drug was promoted as non-addictive and was ...